EXEL
EXELIXIS, INC.
NASDAQ · Healthcare · Biotechnology · US
$58.36
−0.22%Forward multiples
Based on analyst estimates
- P/E forward
- 15.77x
- P/E 2026E
- 16.54x
- P/E 2027E
- 14.01x
- P/E 2028E
- 11.69x
- P/S forward
- 5.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.74x
- PEG TTM
- 1.42x
- Price / book
- 7.84x
- Price / sales
- 5.94x
- Price / cash flow
- 12.22x
Enterprise value
- Enterprise value
- $13.8B
- EV / sales
- 5.66x
- EV / EBITDA
- 13.26x
- EV / EBIT
- 14.19x
- Market cap
- $14.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026